TuHURA Biosciences, Inc.’s HURA share price has surged by 15.70%, which has investors questioning if this is right time to ...

Further on February 24 to 28 this year, 15 laboratory personnel were trained on HLA testing and gaining hands-on experience with the newly acquired equipment ...

Pioneering the World's 1st Dark Matter Cancer Immunotherapy UbiVac's DPV-001 is the World's 1st Dark Matter Cancer Immunotherapy in the Cli ...

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.

Anocca has secured authorisation from regulatory authorities in four European nations for its Phase I/II VIDAR-1 clinical ...

CTA approval marks Anocca’s transition to a clinical-stage companyFirst-in-human VIDAR-1 trial begins with the deployment of ANOC-001 in Advanced ...

Captain Salman Ali Agha made 46 as Pakistan reached 135-9 in a match reduced to 15 overs per innings after a delay for wet ...

European regulators have cleared Anocca to begin a Phase I/II umbrella trial of its lead targeted T-cell receptor (TCR) therapy ANOC-001 and other pipeline candidates in certain advanced pancreatic ...

However, Messi was not selected for international duty with Argentina, with both national team and club claiming he suffered an adductor injury in the Atlanta match. Inter Miami claimed his ...

Match Group, Inc. engages in the provision of digital technologies. It operates through four segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company’s portfolio of ...